Results 181 to 190 of about 5,988 (201)

Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs)

Thrombosis Update, 2021
Dimitrios A Tsakiris, Nikolaos Neokleous, Vasileios Perifanis   +2 more
exaly  

Postprocedural Anticoagulation After LAAO: Comparing DOACs, Warfarin, and Individual DOAC Agents

Circulation: Arrhythmia and Electrophysiology
Yong Hao Yeo, Hermon Kha Kin Wong, Aravinthan Vignarajah, Min Choon Tan, Ramzi Ibrahim, Nishanthi Vigneswaramoorthy, Hicham El-Masry, Justin Z. Lee, Dan Sorajja   +8 more
openaire   +2 more sources

Paxlovid for a Patient on a DOAC

2022
openaire   +1 more source

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment

Journal of Thrombosis and Thrombolysis, 2016
Charles E Mahan, Jack Ansell, Allison E Burnett   +2 more
exaly  

Paxlovid for a patient on DOAC

2022
openaire   +1 more source

Comparison of warfarin versus DOACs in patients with concomitant indication for oral anticoagulation undergoing TAVI; results from the ATLAS registry

Journal of Thrombosis and Thrombolysis, 2019
Richard Jabbour, Vasileios F Panoulas
exaly  

DOACs by Rimsha Ismail

2023
openaire   +1 more source

Perioperative Management of DOACs in Vascular Surgery: A Practical Approach

Current Pharmaceutical Design, 2019
Miltiadis Matsagkas, Petroula Nana, George N. Kouvelos   +2 more
exaly  

Reversal of Newer Direct Oral Anticoagulant Drugs (DOACs)

Cardiovascular and Hematological Agents in Medicinal Chemistry, 2017

exaly  

Direct oral anticoagulant drugs (DOAC)

Journal of Cataract and Refractive Surgery, 2016
Robert A, Blum, Dan, Lindfield
openaire   +2 more sources